Anzeige
Mehr »
Samstag, 14.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
64 Leser
Artikel bewerten:
(0)

Endovascular Aneurysm Repair Market (EVAR) 2015 Trends, Growth Drivers and 2018 Forecasts Discussed in New Research Report

PUNE, India, January 20, 2016 /PRNewswire/ --

The Endovascular Aneurysm Repair (EVAR) market report provides comprehensive research and unbiased analysis of the current market performance and future outlook of the global and regional markets like the US, Europe as well developments in the other regions of the world. Following this, the report provides the reader with an outlook of the current status of EVAR market. It also encompasses a number of factors driving the growth of the EVAR market coupled with recent trends and challenges hindering the growth of the industry.

The Global Endovascular Aneurysm Repair (EVAR) Market Report: 2015 Edition is an industry research of 52 pages published in January 2016, which reviews Medtronic Inc. (Endurant), TriVascular (Ovation Xi) & Lombard Medical (Aorfix) and is now available at http://www.marketreportsonline.com/442402.html.

The aorta is the largest artery in the human body and responsible for distributing blood throughout the entire body. Sometimes there is a localized bulging or abnormal enlargement of the abdominal aorta, called abdominal aortic aneurysm (AAA). AAAs occur most often in Caucasian males over the age of 65 years; they are less common in women. AAA's can be treated using two methods, namely open surgery and endovascular aneurysm repair (EVAR). EVAR is a minimally invasive alternative to major open surgery for the repair of AAA's that results in reduced recovery times and potentially improved survival rates. Endovascular procedures aim to reduce the morbidity and mortality of treating arterial disease in a patient population that is increasingly older and less fit than when major open repairs were developed and popularized.

The research report," Global EVAR Market Report: 2015 Edition" reveals the principal trends of the market, including enhanced demand for percutaneous EVAR by experienced physicians of leading medical institutions. Inclination towards the EVAR market worldwide can be observed as a result of the outcomes delivered by EVAR as compared to open surgery. Other factors include growing numbers of geriatric population and associated expenditure for health care, steadily increasing cases of AAA screening worldwide. Postoperative complications like endoleaks and migration, growing number of regulations posed by regulatory authorities like FDA restrict the market which is the biggest challenge faced by the industry experts. Various trends impacting the market today and in the future take account of ongoing clinical studies, growing use of percutaneous EVAR, preferences for various AAA repair methods, and technological development.

Purchase a copy of this Endovascular Aneurysm Repair (EVAR) Market research report at USD 1200 (Single User License) http://www.marketreportsonline.com/contacts/purchase.php?name=442402.

The market for AAA repair is highly competitive with several players operating both at the global and regional level. The leading players include Medtronic, TriVascular and Lombard Medical. Performance of various companies along with comparative study based on products and services offered by them are introduced along with their key financial, strategies for growth and market share. The increasing competition in the EVAR industry has been analyzed on a variety of factors: revenue, surgical outcomes, postoperative procedures and complications. The report serves as a must read for anyone willing to invest in this promising area and trying to evaluate opportunities. Major Points From List of Tables and Charts:

List of Charts provided in this EVAR market report cover:

AAA Market by Penetration (2015)

AAA Market Segmentation by Patient Anatomy (2014)

The US AAA Market by Number of Diagnosed Cases & Procedures Performed (2014-2020E)

European AAA Market by Number of Diagnosed Cases & Procedures Performed (2014-2020E)

The US AAA Prevalence Model by Gender (2014-2020E)

European AAA Prevalence Model by Gender (2014-2020E)

The US AAA Prevalence Model by Population (2014-2020E)

European AAA Prevalence Model by Population (2014-2020E)

The US AAA Market by Procedure Mix (2014-2020E)

European AAA Market by Procedure Mix (2014-2020E)

Global EVAR Market by Value - Actual (2010-2015E)

Global EVAR Market by Value - Forecast (2016F-2020F)

Global EVAR Market by Region - Actual (2010-2015E)

Global EVAR Market by Region - Forecast (2016F-2020F)

Explore more pharmaceuticals market research as well as other newly published reports by Koncept Analytics at http://www.marketreportsonline.com/publisher/koncept-analytics-market-research.html .

About Us:

Market Reports Online comprises of an online library of 250,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Contact Us:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
Tel: + 1 888 391 5441
E-mail: sales@marketreportsonline.com


© 2016 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.